Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer

Gynecologic Oncology

Volumn 93, Issue 2, 2004, Pages 429-434

  Havrilesky, Laura J ^a   Leath, Charles A ^b   Huh, Warner ^b   Calingaert, Brian ^a   Bentley, Rex C ^a   Soper, John T ^a   Secord, Angeles Alvarez ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cervical cancer; Hysterectomy; Lymphadenectomy

Indexed keywords

CISPLATIN;

ADJUVANT CHEMOTHERAPY; AGE DISTRIBUTION; BLEEDING; CANCER GROWTH; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; CAUSE OF DEATH; COLON STENOSIS; CYSTOCOLIC FISTULA; HIGH RISK POPULATION; HUMAN; KAPLAN MEIER METHOD; LYMPH FLOW; MULTIVARIATE ANALYSIS; PELVIS LYMPHADENECTOMY; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; RACE DIFFERENCE; RADICAL HYSTERECTOMY; REVIEW; SMALL INTESTINE OBSTRUCTION; SURGICAL INFECTION; TREATMENT OUTCOME; URETER FISTULA; UTERINE CERVIX CANCER;

EID: 1942444619     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.01.038     Document Type: Article

References (21)

1. Finan M.A., DeCesare S., Fiorica J.V.et al. Radical hysterectomy for stage IB1 vs. IB2 carcinoma of the cervix: does the new staging system predict morbidity and survival? Gynecol. Oncol. 62(2):1996;139-147.
2. Piver M.S., Chung W.S. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet. Gynecol. 46(5):1975;507-510.
3. Chung C.K., Nahhas W.A., Stryker J.A.et al. Analysis of factors contributing to treatment failures in stages IB and IIA carcinoma of the cervix. Am. J. Obstet. Gynecol. 138(5):1980;550-556.
4. Creasman W.T., Soper J.T., Clarke-Pearson D. Radical hysterectomy as therapy for early carcinoma of the cervix. Am. J. Obstet. Gynecol. 155(5):1986;964-969.
5. Landoni F., Maneo A., Colombo A.et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 350(9077):1997;535-540.
6. Keys H.B.B., Bundy B.N., Stehman F., Okagaki T., Gallup D., Roman L., Fowler W. Radiation therapy with and without extra fascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group. Gynecol. Oncol. 89:2003;343-353.
7. Grigsby P.W. Primary radiotherapy for stage IB or IIA cervical cancer. J. Natl. Cancer Inst. Monogr. 21:1996;61-64.
8. Keys H.M., Bundy B.N., Stehman F.B.et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N. Engl. J. Med. 340(15):1999;1154-1161.
9. Peters W.A. III, Liu P.Y., Barrett R.J. II Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J. Clin. Oncol. 18(8):2000;1606-1613.
10. Delgado G., Bundy B., Zaino R.et al. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol. Oncol. 38(3):1990;352-357.
11. Sedlis A., Bundy B.N., Rotman M.Z.et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol. Oncol. 73(2):1999;177-183.
12. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:1958;457-481.
13. Cox D.R. Regression models and life tables. J. R. Stat. Soc. 34:1972;187-220.
14. Rose P.G., Adler L.P., Rodriguez M.et al. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J. Clin. Oncol. 17(1):1999;41-45.
15. Perez C.A., Grigsby P.W., Nene S.M.et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer. 69(11):1992;2796-2806.
16. Eifel P.J., Morris M., Wharton J.T.et al. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 29(1):1994;9-16.
17. Cosin J.A., Fowler J.M., Chen M.D.et al. Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking. Cancer. 82(11):1998;2241-2248.
18. Buekers T.E., Anderson B., Sorosky J.I.et al. Ovarian function after surgical treatment for cervical cancer. Gynecol. Oncol. 80(1):2001;85-88.
19. Schorge J.O., Molpus K.L., Koelliker D.et al. Stage IB and IIA cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy. Gynecol. Oncol. 66(1):1997;31-35.
20. Monk B.J., Cha D.S., Walker J.L.et al. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma. Gynecol. Oncol. 54(1):1994;4-9.
21. Eifel P.J., Levenback C., Wharton J.T.et al. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 32(5):1995;1289-1300.